Author： Vermeulen R.J. Drukarch B. Wolters E.C. Stoof J.C.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.11, Iss.2, 1999-02, pp. : 83-91
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Are Dopamine Receptor Agonists Neuroprotective in Parkinson's Disease?
Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. :
Access to resources
Recommend
Dopamine agonists cost effective for cotherapy of Parkinson's disease?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 332, 2001-01 ,pp. :
Dopamine Agonists in Parkinsons Disease: What is Their Role in Early Treatment?
By Stocchi F.
CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. :
Dopamine D3 Agonists in the Treatment of Parkinson&aposs Disease
Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. :
Pramipexole: treatment of choice in early Parkinson's disease?
Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. :